NutriSense-3, a Series of Jason’s Syndicate

NutriSense-3, a Series of Jason’s Syndicate

Early Stage

Engage with your blood glucose levels

Engage with your blood glucose levels

Overview

Raised to Date: Raised: $1,848,526

Platform

The Syndicate

Start Date

09/01/2022

Close Date

09/06/2022

Min. Goal
$4,000
Max. Goal
$1,848,526
Min. Investment

$4,000

Security Type

Equity - Common

SEC Filing Type

RegD 506(b)    Open SEC Filing

Status
Funded
Reporting Date

09/29/2022

Days Remaining
Funded
% of Min. Goal
Funded
% of Max. Goal
Funded
Likelihood of Max
Funded
Avg. Daily Raise

$462,132

Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded

2019

Industry

Healthcare & Pharmaceuticals

Tech Sector

HealthTech

Location

Chicago, Illinois

NutriSense is raising funds through NutriSense-3, a Series of Jason’s Syndicate, via a Reg D 506(b) raise. It is a Series LLC investment fund under Jason’s Syndicate of The Syndicate, an angel investing club led by Jason Calacanis. The investors get to join the syndicate, receive deal memos, attend webinars, and decide if they want to invest. NutriSense is a health and wellness company that helps people keep track of their diet, exercise, lifestyle, and sleep patterns. The platform helps people analyze their blood glucose levels in real-time in response to food, exercise, stress, and sleep. Alex Skyrl and Dan Zavorotny founded NutriSense in 2019. The current campaign has a maximum target of $1,848,526.
Create a free account today to gain access to KingsCrowd analytics.

Raise History

Offering Name Close Date Platform Valuation/Cap Total Raised Security Type Status Reg Type
NutriSense-3, a Series of Jason’s Syndicate 09/05/2022 The Syndicate - $1,848,526 Equity - Common Funded RegD 506(b)
Nutrisense, a Series of Jason’s Syndicate 01/30/2022 The Syndicate - $793,923 SAFE Funded RegD 506(b)
Create a free account today to gain access to KingsCrowd analytics.

Price per Share History

Note: Share prices shown in earlier rounds may not be indicative of any stock splits.

Valuation History

Revenue History

Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.

Employee History

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
NutriSense on The Syndicate 2022
Platform: The Syndicate
Security Type: Equity - Common

Follow company

Follow NutriSense on The Syndicate 2022
No Public Offering Page

Buy NutriSense-3, a Series of Jason’s Syndicate's Deal Report

Warning: according to the close date for this deal, NutriSense-3, a Series of Jason’s Syndicate may no longer be accepting investments.

NutriSense-3, a Series of Jason’s Syndicate Deal Report

Get KingsCrowd’s comprehensive report on NutriSense-3, a Series of Jason’s Syndicate including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether NutriSense-3, a Series of Jason’s Syndicate is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the NutriSense-3, a Series of Jason’s Syndicate deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge